Obesity, hormones, and cancer

Area of Science:

• Endocrinology
• Metabolic Disorders
• Oncology

Background:

• Obesity is a complex physiological state characterized by hormonal and metabolic dysregulation.
• These endocrine alterations are increasingly linked to an elevated risk of certain cancers.
• Understanding these hormonal shifts is crucial for assessing obesity-related health risks.

Purpose of the Study:

• To investigate the specific hormonal alterations associated with obesity.
• To explore the potential impact of these hormonal changes on cancer risk.
• To examine the reversibility of these hormonal changes following weight loss.

Main Methods:

• Analysis of hormone production and metabolism in obese individuals.
• Measurement of estrone, androstenedione, estradiol, and testosterone levels.
• Assessment of sex hormone-binding beta-globulin (SHBG) levels and their impact on hormone clearance.
• Evaluation of other hormonal changes including insulin, growth hormone, and prolactin.

Main Results:

• Obesity increases estrone production via extragonadal metabolism of androstenedione.
• Decreased sex hormone-binding beta-globulin in obesity leads to reduced circulating testosterone levels.
• Obesity alters estradiol metabolism, potentially affecting target organ stimulation.
• Weight loss normalizes SHBG, estrogen, and testosterone levels.

Conclusions:

• Obesity induces significant hormonal changes, including elevated estrogens and reduced testosterone, primarily due to altered SHBG and steroid metabolism.
• These hormonal shifts may influence cancer risk, although direct causality requires further investigation.
• Weight loss effectively reverses many of the observed hormonal alterations associated with obesity.